Paola Monti

15PUBLICATIONS
74CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Mar 03, 2026
Tumor patterns and cancer risk in carriers of TP53 exonic germline variants that alter mRNA splicing.

Deborah Schönegger, Emilie Montellier, Sandrine Blanchet

|Dec 05, 2025
Exploring p53 isoforms: unraveling heterogeneous p53 tumor suppressor functionality in uveal melanoma.

Laura Bartolomei, Yari Ciribilli, Samuele Brugnara

|Jun 26, 2025
Targeting the p53/xCT/GSH Axis with PRIMA-1Met Combined with Sulfasalazine Shows Therapeutic Potential in Chronic Lymphocytic Leukemia.

Martina Pasino, Andrea Speciale, Silvia Ravera

|Sep 23, 2024
MicroRNA Profiling as a Predictive Indicator for Time to First Treatment in Chronic Lymphocytic Leukemia: Insights from the O-CLL1 Prospective Study.

Ennio Nano, Francesco Reggiani, Adriana Agnese Amaro

|Jan 26, 2024
PTC596-Induced BMI-1 Inhibition Fights Neuroblastoma Multidrug Resistance by Inducing Ferroptosis.

Giulia Elda Valenti, Antonella Roveri, Rina Venerando

|Aug 12, 2022
The spectrum of subclonal TP53 mutations in chronic lymphocytic leukemia: A next generation sequencing retrospective study.

Giuseppa De Luca, Giannamaria Cerruti, Sonia Lastraioli

Pageof 3

Frequent Collaborators

7 joint publications

Giovanna Cutrona

5 joint publications

Gilberto Fronza

5 joint publications

Fortunato Morabito

4 joint publications

Massimo Gentile